Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Algazi, A. P., Twitty, C. G., Tsai, K. K., Le, M., Pierce, R., Browning, E., Hermiz, R., Canton, D. A., Bannavong, D., Oglesby, A., Francisco, M., Fong, L., Pittet, M. J., Arlauckas, S. P., Garris, C., Levine, L. P., Bifulco, C., Ballesteros-Merino, C., Bhatia, S., Gargosky, S., Andtbacka, R. H., Fox, B. A., Rosenblum, M. D. and Daud, A. I.  Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma.  Clinical Cancer Research.  2020; 26(12), 2827-2837.  doi: 10.1158/1078-0432.ccr-19-2217

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.